Kaplan-Meier survival curves for progression-free survival (A) and overall survival (B) based upon measurable residual disease (MRD) status at the beginning versus the end of maintenance therapy. From Supplemental Figure 8 in Perrot et al., Blood. 2018;132:2456-2464.